Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Trial of an Herbal Liquid Supplement - 'DBPS' for Managing Blood Pressure

Prehypertension is a clinical condition characterized by systolic blood pressure (SBP) readings between 120 and 139 mmHg and/or diastolic blood pressure (DBP) readings between 80 and 89 mmHg, as per the Joint National Committee (JNC 7) and World Health Organization (WHO) guidelines. Individuals falling within this range do not yet meet the criteria for hypertension but are at a significantly elevated risk of progressing to full-blown hypertension and developing associated cardiovascular diseases such as heart attack and stroke. This stage is considered as a critical window for intervention, as timely and appropriate measures can potentially halt or delay the progression to more severe health issues.

Participants needed: 198
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Eetho Brands, IncUpdated: Jun 5, 2026Locations: 4
Eligibility criteria

Men and women between the ages 18 and 65 years, inclusive, at the time of signin... [+6]

Diagnosed with Stage 1 Hypertension (SBP more than 139 mmHg or DBP more than 89... [+10]

Status: Not yet recruiting

Efficacy of CL22205 on Bone Mineral Density and Menopausal Symptoms

The purpose of this study is to evaluate the effect of CL22205 on bone mineral density and menopausal symptoms in women.

Participants needed: 80
Trial details
Age: 55-65Biological sex: FemaleType: InterventionalSponsor: Eetho Brands, IncUpdated: Mar 27, 2025
Eligibility criteria

Healthy females aged between 55 and 65 years with a Body mass index (BMI) of app... [+6]

Consumption of functional food or supplement that modifies body composition, dur... [+21]

Status: Not yet recruiting

Efficacy of CL22205 to Improve Menstrual Discomfort and Quality of Life

The purpose of this study is to evaluate the efficacy of CL22205 to improve menstrual discomfort and quality of life in oligomenorrheic female subjects.

Participants needed: 80
Trial details
Age: 25-35Biological sex: FemaleType: InterventionalSponsor: Eetho Brands, IncUpdated: Mar 7, 2025
Eligibility criteria

Oligomenorrheic females (Menstrual cycle duration between 36-45 days), aged betw... [+6]

History of any gynaecological disorders which effects the study indication. [+16]